US2016206643A1PendingUtilityA1
Anti-obesity composition
Est. expirySep 30, 2033(~7.2 yrs left)· nominal 20-yr term from priority
A61K 36/76A23L 33/105A61K 31/275A61K 9/0095A61K 36/63A23L 2/52A23L 33/10A23G 4/068A61K 31/26A23G 4/12A61K 9/2054A61K 9/4866A61K 36/31A23G 4/06A61P 3/04A61K 9/0053A61K 31/7048A61K 31/05A23L 1/3002A23L 1/30
58
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
An object of the present invention is to provide an obesity-suppressing composition that suppresses fat accumulation in adipocytes and that has an effect of suppressing body weight gain. The present invention provides an obesity-suppressing composition comprising the following components (A) and (B): (A) at least one member selected from the group consisting of oleuropein and hydroxytyrosol; (B) at least one member selected from the group consisting of sulforaphane compounds and willow extract.
Claims
exact text as granted — not AI-modified1 . An obesity-suppressing composition comprising the following components (A) and (B):
(A) at least one member selected from the group consisting of oleuropein and hydroxytyrosol; (B) at least one member selected from the group consisting of sulforaphane compounds and willow extract.
2 . The obesity-suppressing composition according to claim 1 , wherein the composition comprises at least oleuropein.
3 . The obesity-suppressing composition according to claim 1 , wherein the composition comprises at least sulforaphane.
4 . The obesity-suppressing composition according to claim 1 , wherein the composition comprises olive extract and component (B).
5 . The obesity-suppressing composition according to claim 1 , wherein the composition is an oral composition.Cited by (0)
No later patents cite this yet.
References (0)
No backward citations on record.